Bcl9 and Pygo synergise downstream of Apc to effect intestinal neoplasia in FAP mouse models
Por um escritor misterioso
Descrição
Discovery of an Orally Bioavailable Small-Molecule Inhibitor for
TBX3 acts as tissue-specific component of the Wnt/β-catenin
Pygo and BCL9: the Wnt enhanceosome
Chir99021 and Valproic acid reduce the proliferative advantage of
β-catenin obstructs γδ T cell immunosurveillance in colon cancer
The WNT/β‐catenin dependent transcription: A tissue‐specific
β-catenin obstructs γδ T cell immunosurveillance in colon cancer
TBX3 acts as tissue-specific component of the Wnt/β-catenin
BCL9-2 is highly expressed during puberty and pregnancy in the
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Pygo and BCL9: the Wnt enhanceosome
The interactions of Bcl9/Bcl9L with β-catenin and Pygopus promote
Bcl9 and Pygo synergise downstream of Apc to effect intestinal
Cells, Free Full-Text
